Average Co-Inventor Count = 9.85
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Array Biopharma Inc. (40 from 329 patents)
2. Mirati Therapeutics, Inc. (7 from 38 patents)
3. Genentech, Inc. (6 from 3,222 patents)
4. Eli Lilly and Company (2 from 4,446 patents)
5. Celgene Corporation (2 from 549 patents)
6. Cogent Biosciences, Inc. (2 from 2 patents)
7. Genetech, Inc. (1 from 98 patents)
44 patents:
1. 12351581 - Compounds for FGFR inhibition
2. 12281122 - PI3K inhibitors
3. 12187721 - Protein tyrosine phosphatase inhibitors
4. 11964989 - KRas G12D inhibitors
5. 11932633 - KRas G12C inhibitors
6. 11884664 - Protein tyrosine phosphatase inhibitors
7. 11634417 - Protein tyrosine phosphatase inhibitors
8. 11453683 - KRas G12D inhibitors
9. 11267812 - KRAS G12C inhibitors
10. 11028093 - 4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors
11. 10730880 - 4,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitors
12. 10689377 - KRas G12C inhibitors
13. 10633381 - KRas G12C inhibitors
14. 10519126 - Serine/threonine kinase inhibitors
15. 10189845 - 4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors